Skip to main content
Clinical Trials/ACTRN12621001280897
ACTRN12621001280897
Not yet recruiting
未知

A clinical trial examining the effects of SingINg For breathing on quality of life in COPD aNd ILD pAtients

St Vincents Hospital Melbourne0 sites140 target enrollmentSeptember 22, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
St Vincents Hospital Melbourne
Enrollment
140
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St Vincents Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Patient Cohort:
  • 1\.Participants with a confirmed diagnosis of COPD or ILD
  • Diagnosis confirmed on either CT chest scan (within the last 5 years) or lung function testing (within the last 2 years)
  • 2\.On stable treatment for at least 4 weeks
  • Has not started any new or changed existing cardiorespiratory medications (including antibiotics and oral steroids). To be determined by study site clinician.
  • Has not been admitted to hospital with an exacerbations of their underlying disease (COPD or ILD) within the past 4 weeks.
  • 3\.Modified Medical Research Council dyspnoea score grerater than or equal to 2
  • 4\.Aged 18 years or over
  • 5\.Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
  • Carers Cohort (optional):

Exclusion Criteria

  • 1\.Participants cannot be actively undertaking a centre\-based pulmonary rehabilitation program. However past completion of such a program is permitted.

Outcomes

Primary Outcomes

Not specified

Similar Trials